For the purpose, we verified that RUNX2 knockdown was adequate to inhibit the in vitro proliferation, migration, invasion, and chemoresistance of resistant cells in triple negative breast cancer as well as the tumor growth in BALB/c nude mice. This evidence concerns the gene RUNX2 and neoplasm.